Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000170417 | SCV000222846 | likely benign | not specified | 2012-09-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000170417 | SCV000250345 | benign | not specified | 2014-08-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV004020019 | SCV000319943 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001086010 | SCV000556051 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000170417 | SCV000594798 | benign | not specified | 2018-04-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000757302 | SCV000885470 | benign | not provided | 2017-09-17 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV004593996 | SCV005086723 | likely benign | FG syndrome 2 | 2023-07-17 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely benign. Following criteria are met: 0308 - Population frequency for this variant is out of keeping with known incidence of FG syndrome 2 (MIM#300321), with 1 homozygote, 84 heterozygous alleles and 64 hemizygous alleles in gnomAD v2. (SB) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000170417 | SCV005184585 | benign | not specified | 2024-05-26 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000757302 | SCV001932307 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000757302 | SCV001974509 | likely benign | not provided | no assertion criteria provided | clinical testing |